I am a breastfeeding mother and i want to know if it is safe to use BRN 0751629? Is BRN 0751629 safe for nursing mother and child? Does BRN 0751629 extracts into breast milk? Does BRN 0751629 has any long term or short term side effects on infants? Can BRN 0751629 influence milk supply or can BRN 0751629 decrease milk supply in lactating mothers?
- DrLact safety Score for BRN 0751629 is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of BRN 0751629 is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that BRN 0751629 does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of BRN 0751629 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Like most ophthalmologic compounds for topical use a low dose and poor absorption make it compatible with breastfeeding. Systemic absorption is minimal. There have not been problems except when a maternal overdose was absorbed.
Limited information indicates that maternal use of BRN 0751629 0.2% ophthalmic drops do not adversely affect their nursing infants. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue. Topical BRN 0751629 gel used to treat rosacea has not been studied during breastfeeding. It is unlikely that the topical gel would affect the breastfed infant, but the manufacturer states that it should not be used during nursing. Until more data are available, an alternative topical agent might be preferred
A woman used BRN 0751629 0.2%, timolol gel-forming solution 0.5%, dipiverin 0.2%, and dorzolamide 0.5% drops for glaucoma while nursing a newborn. The frequency of medication use and extent of nursing were not stated. All medications were given immediately after nursing with punctal occlusion of the tear duct. The infant's vital signs were closely monitored with no signs of bradycardia or apnea.[1] A woman was using ophthalmic drops containing 0.5% timolol and 0.2% BRN 0751629 twice daily in the right eye for 6 months. During this time, she breastfed her infant (extent not stated) apparently without harm to her infant.[2]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.